Eton Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ETON and other ETFs, options, and stocks.

About ETON

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. 

CEO
Sean E. Brynjelsen
CEOSean E. Brynjelsen
Employees
44
Employees44
Headquarters
Deer Park, Illinois
HeadquartersDeer Park, Illinois
Founded
2017
Founded2017
Employees
44
Employees44

ETON Key Statistics

Market cap
850.32M
Market cap850.32M
Price-Earnings ratio
-168.68
Price-Earnings ratio-168.68
Dividend yield
Dividend yield
Average volume
325.10K
Average volume325.10K
High today
$32.30
High today$32.30
Low today
$29.55
Low today$29.55
Open price
$30.25
Open price$30.25
Volume
250.33K
Volume250.33K
52 Week high
$32.30
52 Week high$32.30
52 Week low
$13.09
52 Week low$13.09

Stock Snapshot

Eton Pharmaceuticals(ETON) stock is priced at $31.17, giving the company a market capitalization of 850.32M. It carries a P/E multiple of -168.68.

During the trading session on 2026-05-05, Eton Pharmaceuticals(ETON) shares reached a daily high of $32.30 and a low of $29.55. At a current price of $31.17, the stock is +5.5% higher than the low and still -3.5% under the high.

Trading activity shows a volume of 250.33K, compared to an average daily volume of 325.1K.

The stock's 52-week range extends from a low of $13.09 to a high of $32.30.

The stock's 52-week range extends from a low of $13.09 to a high of $32.30.

ETON News

TipRanks 4d
Eton Pharmaceuticals Relaunches HEMANGEOL With Exclusive Distribution

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

TipRanks 4d
Eton Pharmaceuticals announces relaunch of Hemangeol

Eton Pharmaceuticals (ETON) announced the relaunch of Hemangeol. Hemangeol is the only FDA-approved treatment for infantile hemangioma, a pediatric rare disease...

People also own

Based on the portfolios of people who own ETON. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.